Intellectual property is at the heart of successful economies around the world. Traditional economic assets, including cash, fixed assets and natural resources are commodities. Only intellectual property can provide unique and proprietary advantages that can propel the earnings and value of those creating and deploying intellectual properties. IPRA, Inc. specializes in the analysis of these most important economic assets.

 

Russell L. Parr, CFA, ASA conducts all assignments. Some of the corporations and universities for which he has conducted valuations and royalty rate studies include

The work conducted for these and other entities involved valuations, infringement litigation testimony, and royalty rate analyses for use by our clients in license negotiations.

 

For example, Russell L. Parr provided royalty rate analyses to AT&T for use as the basis at which to transfer patented technology. His royalty rate opinion for Baxter was used for patent licensing negotiations in the medical products industry.

 

He provided royalty rate opinions to IBM and Rockwell International regarding telecommunication industry patent license negotiations. He provided Mott’s with a royalty rate analyses for use in patent license negotiations in the beverage industry. Hewlett-Packard and Mead-Johnson hired Russell to provide strategic planning advice about intellectual property management.

 

For Dr. Seuss, he provided the estate of Theodor Geisel with a copyright valuation opinion for use in estate tax filings. For Princeton, Rutgers and Carnegie Mellon, he provided royalty rate analyses for use in patent license negotiations. Edwards and Bayer hired Russell to provide patent infringement litigation support, analysis and expert testimony. In fact, Russell Parr has testified at deposition or trail 50 tomes. He has been recognized as an expert in Federal District Courts across the country including Boston, Islip New York, Wilmington Delaware, St. Louis, Seattle, Los Angeles and others.

 

    

Attorneys	Corporations
Akin, Gump, Strauss, Hauer & Feld Buchanan, Ingersoll & Rooney Goodwin Procter Kenyon & Kenyon King & Spalding Morgan, Lewis & Bockius Quinn Emanuel Wolf, Greenfield & Sacks	AT&T AlliedSignal Baxter International BioNumerik Pharmaceuticals IBM Hewlett Packard Merck & Co Mott’s North America